HAE

Haemonetics Corporation

$122.36

3.51%
SectorHealthcareIndustryMedical DevicesCountryUnited States

Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions. The company operates through Plasma, Blood Center, and Hospital segments. It provides automated plasma collection systems, donor management software, and supporting software solutions, such as NexSys PCS plasmapheresis equipment system and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 tools. The company also offers treatment in electrophysiology, critical care, neurocritical care, trauma, burn surgery, spine surgery, and cancer surgery; SavvyWire, a sensor-guided 3-in-1 guidewire for TAVR procedures; and OptoWire, a pressure guidewire that measures fractional flow reserve and diastolic pressure ratio, as well as fiber optic sensor solutions used in medical devices and other critical industrial applications.

Source: Yahoo Finance
AI summary

Price & performance

1M+13.9%
3M+50.1%
YTD+50.0%
1Y+134.3%
52-week range—
Beta0.58
Full chart and returns against a benchmark

Q-Score

64/ 100

Quality against peers; 50 is the peer median.

Growth58
Risk69
Performance56
Valuation55
Profitability67
Leverage59
Sentiment49
Every score and metric

News sentiment

Open News

Latest results · FY 2026

Revenue$1.3B-2.0%
Net income$97.3M-42.0%
Net margin7.3%-5.0 pts
Historical fundamentals

Revenue exposure

26%of revenue from outside the US
United States74%
Europe14%
Asia7%
Largest customer13%
Regions, segments, customers and suppliers

Valuation

HAEIndustryP/E53.6229.61P/S4.033.49EV/EBITDA22.4618.38P/B6.203.39PEG——
Dividend yield0.00%
Every valuation metric

Earnings

Feb 4next report, before the open
EPS estimate$1.29
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate